Categories AlphaGraphs, Earnings, Health Care
Key highlights from Merck’s (MRK) Q3 2025 earnings results
Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today.
Total worldwide sales of $17.3 billion were up 4% from the same period a year ago. Excluding the impact of foreign exchange, sales grew 3%.
GAAP net income increased 83% to $5.8 billion and EPS increased 87% to $2.32 compared to last year. Adjusted EPS rose 64% to $2.58.
For full-year 2025, the company now expects worldwide sales to be between $64.5-65.0 billion. Adjusted EPS is expected to be $8.93-8.98.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
